Jump to content

Artemisia annua

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 64.44.8.82 (talk) at 21:15, 21 November 2006 (References). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Artemisia annua
Scientific classification
Kingdom:
Division:
Class:
Order:
Family:
Genus:
Species:
A. annua
Binomial name
Artemisia annua
L.

Artemisia annua, also known as Sweet Wormwood, Sweet Annie, or Chinese wormwood (Chinese: 青蒿; pinyin: qīnghāo), is a common type of wormwood that grows throughout the world. It has fern-like leaves, bright yellow flowers, and a camphor-like scent. It averages about 2 m tall and has a single stem, alternating branches, and alternating leaves which range 2.5-5cm in length. It is cross-polinated by the wind or insects. It is a diploid organism with chromosome number, 2n=36.

Sweet Wormwood was used by Chinese herbalists in ancient times to treat fever, but had fallen out of common use, to be rediscovered in 1970 when the Chinese Handbook of Prescriptions for Emergency Treatments (340 AD) was found. This pharmacopeia contained recipes for a tea from dried leaves, prescribed for fevers (not specifically malaria). In 1971, scientists demonstrated that the plant extracts had antimalarial activity in primate models, and in 1972 the active ingredient, artemisinin (formerly referred to as arteannuin), was isolated and its chemical structure described. Artemisinin may be extracted using a low boiling point solvent such as diethyether and is found in the glandular trichomes of the leaves, stems, and inflorescences, and it's concentration is evenly distributed throughout the plant. Artemisinin itself is a sesquiterpene lactone with an endoperoxide bridge and has been produced semi-synthetically as an antimalarial that is commonly used in tropical nations which can afford it, preferentially as part of a combination-cocktail with other antimalarials in order to prevent the development of parasite resistance.

Tea made from A. annua can be used to treat malaria, but the effect is inferior to those of modern artemesinin preparations, possibly because the concentrations achieved are lower and extraction of the active component is unpredictable.[1][2]

The plant has also been shown to have anti-cancer properties. It is said to have the ability to be selectively toxic to breast cancer cells [citation needed] and some form of prostate cancer, there have been exciting preclinical results against leukemia [1], and other cancer cells.

The method of action of the active compound is that it reacts with iron, producing harmful free radicals which damage biological macromolecules including the cell membrane. Malaria is caused by the Apicomplexan, Plasmodium falciparum, which largely resides in red blood cells where there is plenty of iron and cancer cells tend to have higher iron concentrations than normal cells associated with their rapid growth rate.

References

  1. ^ Mueller MS, Runyambo, Wagner I; et al. (2004). "Randomized controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malaria". Trans R Soc Trop Med Hyg. 98: 318–21. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  2. ^ Räth K, Taxis K, Walz GH; et al. (2004). "Pharmacokinetic study of artemisinin after oral intake of a traditional preparation of Artemisia annua L. (annual wormwood)". Am J Trop Med Hyg. 70: 128–32. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)

Novartis' malaria drug Coartem stems from this plant , a cure for fever. Mention of the plant, sweet wormwood-or Artemisia annua L. was found in a Chinese medicine book written on silk, unearthed from a tomb of the West Han Dynasty, which began around 200.B.C Chinese military scientists developed the drug from the plant in the 1970s to treat Chinese soldiers suffering from malaria in Vietnam. In the early 1990s, Novartis struck a deal with the Chinese to buy the rights to Coartem, a combination of a derivative of the plant and another antimalarial treatment, paying a few million dollars up front and royalties on future sales. (excerpt from the Wall Street Journal-November 15,2006)